CorMedix Inc. — Director's Dealing 2012

Sep 24, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CorMedix Inc. (CRMD)
CIK: 0001410098
Period of Report: 2012-09-20

Reporting Person: Lefkowitz Steven W (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-09-20	Senior Convertible Note (convertible into Common Stock)	$0.35	P	1	Acquired	2013-09-20	Common Stock, $0.001 par value per share (100000)	Indirect
2012-09-20	Warrant (right to purchase Common Stock)	$0.40	P	1	Acquired	2017-09-20	Common Stock, $0.001 par value per share (87500)	Indirect
2012-09-20	Senior Convertible Note (convertible into Common Stock)	$0.35	P	1	Acquired	2013-09-20	Common Stock, $0.001 par value per share (42857)	Direct
2012-09-20	Warrant (right to purchase Common Stock)	$0.40	P	1	Acquired	2017-09-20	Common Stock, $0.001 par value per share (37500)	Direct

Footnotes

F1: On September 20, 2012, the reporting person acquired, indirectly through Wade Capital Corporation (an entity for which he has voting and investment control) in a private placement $35,000 of (i) 9% Senior Convertible Notes, convertible into shares of the Company's Common Stock, $0.001 par value per share, at a conversion price of $0.35 per share; and (ii) a five-year redeemable warrant to purchase common stock at an exercise price of $0.40 per share.

F2: On September 20, 2012, the reporting person acquired directly ) in a private placement $15,000 of (i) 9% Senior Convertible Notes, convertible into shares of the Company's Common Stock at a conversion price of $0.35 per share; and (ii) a five-year redeemable warrant to purchase common stock at an exercise price of $0.40 per share.